28.50067.65% ( +11.500 )
Closed: Nov 13, 16:00:00 (EDT)Overview
Windward Bio Group AG (WWB)
Windward Bio Group AG operates as a clinical stage biotechnology company that develops ultra-long-acting antibody medicines for patients with respiratory and de...
- Open
- 18.350
- High
- 33.985
- Low
- 18.350
- Prev. Close
- 17.000
- Volume
- 1.28M
- Turnover
- 31.88M
- Avg Price
- 24.853
- Bid/Ask Ratio
- 33.33%
- Amplitude
- 91.97%
- 52wk High
- 33.985
- Volume Ratio
- 0.00
- Turnover Ratio
- 3.37%
- 52wk Low
- 18.350
- Float Mkt Cap
- 1.08B
- Market CapUSD
- 1.65B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -1.18
- EPSDynamic
- -1.47
- EPSStatic
- --
- BVPS
- 4.58
- P/B
- 6.22
- Circulating Supply
- 38.04M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 58.04M
- Min lot size
- 1
- Currency
- USD
News
PUBT · Windward Bio prices $175 million Nasdaq IPO
RenaissanceCapital · US IPO Weekly Winners & Losers
Simplywall · 2 Reasons Windward Bio Group (WWB) Looks Pricey Following Its Shelf Filing
MSN · Windward Bio IPO jumps 68% though twice-yearly asthma antibody has no flare-up data yet
PR Newswire · Innovative Immunology Biotech Windward Bio Lists on Nasdaq
TradingView · Windward Bio Shares Close 68% Above $17 IPO Price
